Find Local Doctors has recently chosen Creative Dentistry of Covington in Covington, GA , as a 2022 Top Patient Rated Dentist due to excellent reviews and five-star ratings.

COVINGTON, Ga. , May 2, 2022 /PRNewswire-PRWeb/ -- Creative Dentistry of Covington is dedicated to providing families with the comprehensive and convenient dental care that they deserve. The dental team at this clinic truly value their patients and strive to help them attain healthy, functional and beautiful smiles for a lifetime. Positive patient reviews and testimonials have helped the practice earn the distinction of being selected as a 2021 Top Patient Rated Covington Dentist by Find Local Doctors. Find Local Doctors is a trusted online directory that helps consumers easily locate exceptional, reputable dentists and physicians in their area.

With extensive expertise, cutting-edge dental technology and high-quality dental materials, the Creative Dentistry of Covington team provides excellence in general, cosmetic and restorative dentistry. Anitha Reddy , DMD, FAGD, leads the clinic and is a highly skilled dentist with over 25 years of experience in the dental field. She practices all aspects of general dentistry and facial aesthetics; however, she specializes in implant dentistry, cosmetic dentistry and adult orthodontics, such as Invisalign. Creative Dentistry of Covington uses the latest in advanced technology to make a patient's time in the dental chair more comfortable, efficient and enjoyable. Creative Dentistry of Covington helps getting the dental care patients need easy by offering flexible scheduling options and accepting most insurance plans for those in the Covington , Monroe and Conyers areas.

"It is an honor to receive this award. We hope to always exceed our patients' expectations and provide the very best in comprehensive dentistry," says Dr. Anitha Reddy .

More About Creative Dentistry of Covington :

The team of committed and highly-skilled dental professionals at Creative Dentistry of Covington provides comprehensive dental care to the residents of the greater Covington area and the surrounding communities. For more information or to schedule an appointment at Creative Dentistry of Covington (4139 Baker St NE, Building #15), please call 770-787-1013 or visit http://www.creativedentistryofcovington.com.

With dental offices in Atlanta /Sandy Springs , Alpharetta and Covington , this state-of-the art practice provides excellence in dental care for the entire family. For information on the Creative Dentistry & Med Spa Atlanta/Sandy Springs location (5505 Peachtree Dunwoody Rd , Building #460), please call 404-883-3287 or for the Alpharetta location (5755 North Point Pkwy, Ste 102) call 770-676-2476, and visit http://www.creativedentistryofatlanta.com.

Dr. Anitha Reddy , Creative Dentistry of Covington , 770-787-1013, care@creativedentistryofcovington.com

SOURCE Creative Dentistry of Covington

What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.

Shares of Iovance Biotherapeutics (NASDAQ: IOVA) are down 53% as of 12:24 p.m. ET Friday, according to data from S&P Global Market Intelligence, following the release of disappointing results from a pivotal melanoma drug trial released Thursday evening. Iovance had already reported solid results for melanoma treatment Lifileucel in the middle of last year, ultimately finding a response rate of 36%. This follow-on study of cancer patients with advanced melanoma who had shown improvement after previously receiving and responding to anti-PD-1/L1 therapies isn't as encouraging, with an objective response rate of only 29%.

Mirati is unlikely to carve out a share of the lung cancer market, analysts said Friday as MRTX stock collapsed on a testing disappointment.

A Central Florida man survived what doctors call an “exploding heart.”

The company's protein-based shot has been authorized or approved in several other countries, including the U.K. and Singapore.

The stocks for companies developing cancer therapies were moving in morning trading on Friday as biotechs and researchers shared new clinical findings in advance of next week’s American Society of Clinical Oncology annual meeting. Arcellx Inc.’s (ACLX) stock jumped 11.9% after an abstract provided updated data for its CART-ddBCMA. SVB Securities analysts said in a note on Friday that they were pleased to see that the experimental therapy “continues to have a competitive efficacy signal in 24 evaluable relapsed/refractory patients.”

Eli Lilly said Friday it will unveil new test results for its biggest cancer drug, Verzenio, in June and LLY stock broke out to a fresh high.

Pfizer’s promising ulcerative colitis treatment could generate $1.9 billion in sales by 2030. Lilly’s got a drug in development, too.

Many of us grew up hearing that breakfast is the most important meal of the day. By literally "breaking the fast" that you observed while sleeping, the first meal preps your mind and body to take on the rest of your day—and the cup of coffee certainly doesn't hurt. Now, new research has found that adding one fruit to your morning meal could help lower your risk of developing dementia. Read on to find out what researchers suggest adding to your plate to decrease your chances of cognitive decline.

One day, doctors may be able to treat cataracts with a drug instead of surgery.

Americans are getting older and needing more colonoscopies. Private equity, seeing a “Golden Age of older rectums,” is buying up gastroenterology practices.

SHANGHAI/BEIJING (Reuters) -Shanghai took more gradual steps on Friday towards lifting its COVID-19 lockdown while Beijing was investigating cases where its strict curbs were affecting other medical treatments as China soldiered on with its uneven exit from restrictions. The financial hub and the capital have been hot spots, with a harsh two-month lockdown to arrest a coronavirus spike in Shanghai and tight movement restrictions to stamp out a small but stubborn outbreak in Beijing. Elsewhere, some border areas in the northeastern province of Jilin reported transmissions of the virus with an unclear source.

SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian cancer. The trial evaluated SELLAS' peptide immunotherapeutic combined with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab). Data from 15 patients enrolled in the study has been preliminarily analyzed. Final data for all 17 patients is expected by the end of 2022. Related: Sellas Life Sciences Re

For instance, small-cap companies -- that is, those with market caps between $300 million and $2 billion -- tend to carry above-average risk. Let's look at two small-cap companies that could double your money within the next couple of years and deliver solid returns in the long run if they can navigate the road ahead: BioXcel Therapeutics (NASDAQ: BTAI) and Planet 13 Holdings (OTC: PLNH.F). The biotech currently boasts a market capitalization of $379 million and a share price of $11.75.

One of Greater Cincinnati's largest public companies will help other diagnostic businesses develop monkeypox tests.

At this point in the pandemic, it's fairly likely you've had COVID at least once, as the Centers for Disease Control and Prevention (CDC) has estimated that there have been more than 83 million coronavirus infections in the U.S. alone, which translates to around 60 percent of all Americans. Our country has also reached the tragic milestone of one million COVID deaths, while infections and hospitalizations are rising once again. Since the end of 2020, however, virus experts have continued to push

Wearables can provide key data to help individuals bolster their mental health, Whoop founder and CEO Will Ahmed recently told Yahoo Finance.

The fact that Black people are at higher risk for cardiovascular disease than whites isn’t exactly news. But a new Northwestern Medicine study has confirmed something that Black people have known all along – that the difference has less to do with genetics and more to do with environmental and social factors.

There is a clear disconnect across the U.S. in terms of the COVID pandemic right now. Some people are planning summer vacations, while others are masking back up as coronavirus cases start climbing back up. More than half of the U.S. population is still experiencing low virus transmission, but infections are rising, and many areas across the country have moved into medium and high levels of community spread, according to the Centers for Disease Control and Prevention (CDC). The agency's latest d

BridgeBio Pharma Inc (NASDAQ: BBIO) has announced interim Phase 1 data from healthy volunteers, supporting the development of BBP-671 for pantothenate kinase-associated neurodegeneration (PKAN) and organic acidemias. BBP-671 is being developed as a potential therapy for diseases in which coenzyme-A (CoA) metabolism is deficient, including PKAN, propionic acidemia (PA), and methylmalonic acidemia (MMA). BBP-671 was detected in healthy volunteer plasma and cerebrospinal fluid (CSF), which suggests